A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8500-8500
◽
I. N. Micallef
◽
M. J. Maurer
◽
D. A. Nikcevich
◽
M. Cannon
◽
D. F. Moore
◽
...